The dose that works isn't the dose you'd guess - here's what the research actually supports.
Sarcopenia - the age-related loss of muscle mass, strength and function - doesn't wait for a diagnosis to start. It's a slow leak, not a cliff edge, and the training that protects against it isn't the punishing, everything-hurts session you might picture. It's a specific, repeatable dose. The research on what that dose actually looks like has had a significant year, and it's worth building your programme around it rather than around guesswork.
What the sarcopenia-specific research found
A 2025 systematic review and meta-analysis in BMC Geriatrics looked specifically at resistance training in older adults with sarcopenia and pulled apart which training variables actually moved the needle on strength and physical performance. Two findings stand out, and both cut against the "more is better" instinct.
First, frequency: training twice a week had a significant positive effect on grip strength, while training three times a week didn't reliably improve on that. Second, intensity: moderate-intensity training (around Borg RPE 12-13, roughly 50-69% of 1RM) was sufficient to produce significant effects, and pushing into moderate-to-vigorous intensity showed limited additional benefit for this population. The sets and reps used across the trials were unremarkable - 2-3 sets per exercise, around 10 reps - run over programmes lasting 8 to 26 weeks.
Worth being straight about a limitation here too, in the spirit of showing the working rather than the highlight reel: resistance training in this review didn't significantly shift skeletal muscle mass index. The benefit showed up in grip strength and physical performance, not necessarily in muscle mass on a scan. For sarcopenic populations specifically, function is the win, and it's a real one.
What the broader older-adult dose-response research adds
A 2015 Sports Medicine systematic review and meta-analysis looked at dose-response relationships in healthy older adults more generally, and it gives you the numbers to build with once you're past the sarcopenia-specific floor. For strength gains, two sessions a week outperformed three in the pooled analysis. Intensity in the 70-79% of 1RM range produced the largest effects. Two to three sets per exercise, and seven to nine reps per set, was the sweet spot - not the high-rep "toning" approach often pushed at older trainees, and not maximal singles either. Time under tension mattered too: around six seconds per rep showed the biggest effect, which in practice means controlling the rep rather than throwing weight around.
The other detail worth sitting with: the biggest strength gains in that review came from programmes running 50-53 weeks. This isn't a six-week fix. It's a training age effect - the longer you're consistently in the dose range, the more you get out of it.
Building the routine
Put those two bodies of evidence together and a sensible strength routine against sarcopenia looks like this:
- Frequency: two focused full-body or upper/lower split sessions a week, covering the major muscle groups. A third session is fine if you enjoy it, but the evidence doesn't say you need it for strength.
- Intensity: working sets at 70-79% of 1RM for your main lifts once you're established. If you're deconditioned, returning from injury, or genuinely frail, moderate intensity (roughly 50-69% 1RM) is a legitimate, evidence-backed starting point - not a compromise.
- Volume: 2-3 sets per exercise, 7-9 reps for strength-focused work.
- Tempo: control the eccentric and concentric, aiming for a few seconds under tension per rep rather than bouncing through it.
- Horizon: think in seasons, not weeks. The research rewards people who are still doing this at week 50.
This lines up with the American College of Sports Medicine's 2026 position stand on resistance training prescription - its first major update in 17 years, built from an overview of 137 systematic reviews covering more than 30,000 participants. It recommends around 80% of 1RM for 2-3 sets per exercise when strength is the goal, and it's explicit that training to muscular failure, specific equipment choices and complex periodisation schemes aren't necessary for the average healthy adult to get strong. What matters more than any of that is hitting each major muscle group with real intent at least twice a week, consistently.
The long game
None of this is exciting. There's no hack, no single exercise, no supplement that substitutes for two properly loaded sessions a week, run for a year, at an intensity you can actually sustain. That's the whole point. Sarcopenia is a slow process, so the defence against it has to be one too - shown up for, logged, repeated. Build the routine at the dose the evidence supports, then just keep training.
Sources
- Dose-response effects of resistance training in sarcopenic older adults: systematic review and meta-analysis. BMC Geriatrics, 2025. - https://link.springer.com/article/10.1186/s12877-025-06559-4
- Dose-Response Relationships of Resistance Training in Healthy Old Adults: A Systematic Review and Meta-Analysis. Sports Medicine, 2015. - https://link.springer.com/article/10.1007/s40279-015-0385-9
- American College of Sports Medicine Position Stand. Resistance Training Prescription for Muscle Function, Hypertrophy, and Physical Performance in Healthy Adults: An Overview of Reviews. - https://pubmed.ncbi.nlm.nih.gov/41843416/
- ACSM Unveils 2026 Resistance Training Guidelines - First Update in 17 Years. - https://acsm.org/resistance-training-guidelines-update-2026/